ES

Emily Smith

National Director, Commercial Training And Development at Syndax

Emily Smith is a seasoned professional in the pharmaceutical industry with extensive experience in commercial training, patient access, and strategic development. Currently serving as the National Director of Commercial Training and Development at Syndax Pharmaceuticals, Emily previously held the position of National Associate Director at Amgen, where significant contributions were made to improve patient access in rare diseases. Prior roles include Associate Director at Horizon, where Emily received the top President’s Club honor and led national training initiatives, as well as various leadership positions at Sanofi Genzyme, focusing on training execution and reimbursement processes. Earlier in the career, Emily excelled at Teva Neuroscience, earning awards for leadership and excellence. Emily holds a BBA in Marketing from the SMU Cox School of Business.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Syndax

Syndax Pharmaceuticals, Inc (Syndax) is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The Company’s product candidate, entinostat, which was granted Breakthrough The...


Industries

Employees

51-200

Links